These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34248548)

  • 1. Posterior Reversible Encephalopathy Syndrome Associated with Oxaliplatin Use for Pancreatic Adenocarcinoma.
    Symeonidis DG; Liatsos AD; Mazlimoglou EK; Geraki EC; Kosmas C
    Case Rep Oncol; 2021; 14(2):838-844. PubMed ID: 34248548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy.
    Gandini J; Manto M; Charette N
    Front Neurol; 2019; 10():1405. PubMed ID: 32082236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant Type of Posterior Reversible Encephalopathy Syndrome Associated with Deep Brain Hemorrhage: Case Report and Review of the Literature.
    Yamagami K; Maeda Y; Iihara K
    World Neurosurg; 2020 Feb; 134():176-181. PubMed ID: 31712110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Posterior reversible encephalopathy syndrome].
    Petrović B; Kostić V; Sternić N; Kolar J; Tasić N
    Srp Arh Celok Lek; 2003; 131(11-12):461-6. PubMed ID: 15114789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report.
    Egoryan G; Murguia-Fuentes R; Agab M; Abou-Ghanem N; Yanez-Bello MA; Pyakuryal B; Trelles-Garcia DP; Ibrahim R; Filipiuk D; Gidron A; Rodriguez-Nava G
    J Med Case Rep; 2021 Apr; 15(1):161. PubMed ID: 33840384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
    Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
    Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome With Atypical Regions: A Descriptive Study With a Large Sample Size.
    Li K; Yang Y; Guo D; Sun D; Li C
    Front Neurol; 2020; 11():194. PubMed ID: 32265829
    [No Abstract]   [Full Text] [Related]  

  • 8. Posterior reversible encephalopathy syndrome following elevated mean arterial pressures for cervical spinal cord injury.
    Zimering JH; Mesfin A
    J Spinal Cord Med; 2018 Jan; 41(1):111-114. PubMed ID: 27917700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
    Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
    Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.
    How J; Blattner M; Fowler S; Wang-Gillam A; Schindler SE
    Neurologist; 2016 Nov; 21(6):112-117. PubMed ID: 27801773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.
    Yang Q; Chang CC; Liu M; Yu YQ
    BMC Med Imaging; 2019 Apr; 19(1):35. PubMed ID: 31039748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PRES (Posterior Reversible Encephalopathy Syndrome): potential complication of hypertensive crisis. Case report and literature review].
    Vergura M; Prencipe M; Del Giudice AM; Grifa R; Miscio F; Pennelli AM; Popolizio T; Simeone A; Ferrara M; Leone M; Aucella F
    G Ital Nefrol; 2017 Apr; 34(2):100-109. PubMed ID: 28682567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
    Magaña SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
    Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
    Skelton MR; Goldberg RM; O'Neil BH
    Clin Colorectal Cancer; 2007 Jan; 6(5):386-8. PubMed ID: 17311705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood posterior reversible encephalopathy syndrome: Magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal.
    Agarwal A; Kapur G; Altinok D
    Neuroradiol J; 2015 Dec; 28(6):638-43. PubMed ID: 26515749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior reversible encephalopathy syndrome: magnetic resonance imaging and diffusion-weighted imaging in 12 cases.
    Chou MC; Lai PH; Yeh LR; Li JY; Yuan MK; Liang HL; Chen C; Pan HB; Lo YK; Yang CF
    Kaohsiung J Med Sci; 2004 Aug; 20(8):381-8. PubMed ID: 15473649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.
    Tetsuka S; Nonaka H
    BMC Med Imaging; 2017 May; 17(1):35. PubMed ID: 28545408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epileptic Ictal Hyperperfusion on Arterial Spin Labeling Perfusion and Diffusion-Weighted Magnetic Resonance Images in Posterior Reversible Encephalopathy Syndrome.
    Wakisaka K; Morioka T; Shimogawa T; Murao K; Kanazawa Y; Hagiwara N; Arakawa S
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):228-37. PubMed ID: 26515648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).
    Janjua TK; Hassan M; Afridi HK; Zahid NA
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
    Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
    Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.